Navigation Links
Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award
Date:3/30/2010

David L. Rimoin, MD, PhD, FACMG of Cedars-Sinai Medical Center in Los Angeles, was presented the American College of Medical Genetics Foundation (ACMGF) second annual Lifetime Achievement Award at its 2010 Annual Meeting.

Dr. Rimoin was recognized for his decades of contributions to genetic medicine, for his research into skeletal dysplasias and heritable disorders of connective tissue, and for helping to organize the field of medical genetics into creditable associations like the ACMG.

Presented the Award at the 2010 ACMG Annual Clinical Genetics Meeting in Albuquerque, New Mexico, Dr. Rimoin was cheered by colleagues, former students, friends and family.

Attendees from more than 29 countries participated in the event.

"Dr. Rimoin is one of the true giants of medical genetics. He's made enormous contributions in every facet of medical genetics. He is extraordinary in terms of his contribution to our profession and his teaching and work has inspired a tremendous number of geneticists," said R. Rodney Howell, MD, FACMG, president of the American College of Medical Genetics Foundation.

"It's a great honor," said Dr. Rimoin of receiving the award. "It's amazing to be recognized by your peers this way."

Born in 1936 in Montreal, Canada, Dr. Rimoin is best known for his research on short stature and skeletal dysplasias and heritable disorders of connective tissue.

He is Director of the International Skeletal Dysplasia Registry, the largest such registry in the world. A prolific writer, he has written articles for more than 410 peer-reviewed publications. His textbook, "Emery and Rimoin's Principles and Practices of Medical Genetics," is currently in its fifth edition.

Following a childhood dream of becoming a doctor, Dr. Rimoin chose genetics as a way to gain entrance to McGill University medical school.

"Ever since I was four or five years old I wanted to be a doctor," he said. "There was nobody in my family that had been in medicine and in fact no one had gone to college.

"I had to figure out a way to get into medical school. I figured I would get into a program that would allow me to meet people and get a good biology background and a new program in genetics opened up."

Dr. Rimoin excelled at McGill where he earned his bachelor's degree with honors in genetics in 1957, his MD and MSc in 1961 and then his doctorate in human genetics from Johns Hopkins University School of Medicine where he was recruited by the late Dr. Victor McKusick, in a phone call he will never forget.

"I started an internship in internal medicine at McGill and I was standing over a child dying of cystic fibrosis one day and I get a call from, so they said, was Victor McKusick. I thought someone was pulling my leg because he was the most famous person in genetics.

"He said, 'I've heard about you and I want you to come work with me'," Dr. Rimoin recalled.

What followed was a long and distinguished career of research and leadership in genetics during which he helped organize his profession into associations like the ACMG.

"It was a chance to get medical geneticists recognized as experts in the field and push for funding and medical changes in insurance and the nation to transform a new science into a medical specialty and bring people together to share ideas and to encourage young people to go into the training programs to increase the number of medical geneticists."

Dr. Rimoin is presently Professor of Pediatrics, Medicine, and Human Genetics at the David Geffen School of Medicine at UCLA and Steven Spielberg Chair and Director of the Medical Genetics Institute at Cedars-Sinai Medical Center in Los Angeles.

He was the founding president of the American Board of Medical Genetics (1979�), the founding president of the American College of Medical Genetics (ACMG) (1992�) and president of the American Society of Human Genetics (1984).

Dr. Rimoin is responsible for the creation of the Medical Genetics Clinic at the Barnes and Children's Hospitals of St. Louis, and the Division of Medical Genetics in the Departments of Medicine and Pediatrics at Harbor-UCLA and the Medical Genetics Institute at Cedars-Sinai Medical Center. He is also the director of the UCLA Intercampus Genetics Postdoctoral program.

Dr. Rimoin's work is renowned and has earned him a reputation as a true leader, teacher and administrator, in the field of medical genetics.

"This award is an obvious reflection of (Dr. Rimoin's) lifetime achievement, which is almost unique in our field," said Dr. Rimoin's longtime friend and colleague, Dr. Michael Kaback, Professor Emeritus of Pediatrics and Reproductive Medicine and the Division of Medical Genetics, at the University of California-San Diego.

"No one has contributed more in the global sense in terms of our understanding of the fundamental nature of a very complex group of disorders involving hereditary defects of bone and cartilage, which has been David's passion for all of his professional life," Kaback said.


'/>"/>

Contact: Kathy Ridgely Beal, MBA
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. Silicon Valley Technology Leaders LaserCard Corporation and Tesla Motors Sign LaserPass Secure Access Deal
2. Leaderless movement proves illusive
3. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
4. Entrust Continues Leadership by Adding Support for Next-generation E-Passports
5. IEEE-USA innovation forum will help prepare US tech leaders to prosper in a global marketplace
6. Stronger EPA leadership needed to improve water quality in Mississippi River
7. Toxic releases down from North American industry leaders, increasing from other facilities
8. Abel to receive posthumous Ocean and Coastal Leadership award
9. UCSD bioengineering grad student wins leadership award
10. Too few women scientists achieving academic leadership positions
11. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building ... corporate rebranding initiative announced today. The bold new look is part of a ... company moves into a significant growth period. , It will also expand its service ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology: